Home

Features

  • Tariffs & Pharma: What May Be Next?ByPatricia Van Arnum

    Tariffs & Pharma: What May Be Next?
    By

    The pharma industry weighs in on the impact that US-imposed tariffs would have on products, manufacturing, and supply chains, particularly for generic drugs. With much uncertainty looming on how trade policy has and will evolve under a new US Administration, what is the latest?


  • Risks & Rewards: What’s on the Minds of CEOs?ByPatricia Van Arnum

    Risks & Rewards: What’s on the Minds of CEOs?
    By

    While CEOs are optimistic about the global economy, macroeconomic volatility, inflation, and geopolitical uncertainty top the lists of risks of greatest concern, according to PwC’s 2025 Global CEO Survey, which fielded feedback from more than 4,700 CEOs globally across all industries.


DCAT MEMBER COMPANY COMMUNITY